Amer Zeidan

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

Amer Zeidan
Apr 27, 2025, 16:00 | Blog
Amer Zeidan: Yale Cancer Center is looking for a junior clinical investigator to join the myeloma program
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X:…
Apr 14, 2025, 08:24 | Blog
Mikkael A. Sekeres: MPN-MDS Meeting in Austin With OG MDSsm Superstar Doctors
Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared…
Apr 11, 2025, 10:46 | Blog
Amer Zeidan: A true pleasure to visit Stanford University to give a Breakthroughs in Hematology talk
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X:…
Jan 23, 2025, 14:32 | Blog
Amer Zeidan: Insights from the Most Important MDS Studies at ASH24
IACH (International Academy for Clinical Hematology) shared the following on X: “Now available on-demand! Our…
Jan 15, 2025, 05:26 | Blog
IACH - Amer Zeidan on the Most Important MDS Studies from ASH24
IACH shared on X: "Join us for the next IACH post ASH24 webinar: Most Important MDS…
Jan 4, 2025, 13:13 | Insight
Amer Zeidan: Reducing Clinical Trial Eligibility Barriers for Myelodysplastic Syndromes/Neoplasms
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X,…
Dec 19, 2024, 21:47 | Blog
Amer Zeidan: As 2024 winds down, I contemplate
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X:…
Dec 12, 2024, 13:11 | Societies
Highlights from Day 4 of 66th ASH Annual Meeting
The 66th ASH Annual Meeting and Exposition was held from December 7-10, 2024, in San…
Dec 11, 2024, 17:22 | Blog
Jessica M. Stempel on Aza-Ven +/- Pembro in older AML
Amer Zeidan, Associate Professor of Medicine at Yale University, shared a post on X: "Dr.…
Dec 11, 2024, 11:27 | Blog
Dr Abdulrahman Alhajahjeh shares cost effectiveness of transplant in intermediate risk AML
Amer Zeidan shared on X: "Dr Abdulrahman Alhajahjeh did an outstanding job to present on behalf…
Dec 8, 2024, 04:20 | Insight
Amer Zeidan: Global Disparities in Characteristics and Outcomes of Leukemia Clinical Trials
Amer Zeidan, Associate Professor of Medicine at Yale University, shared an article by Abdulrahman Alhajahjeh on…
Nov 29, 2024, 15:31 | Insight
Thanksgiving Day 2024: A Time for Gratitude and Reflection
Thanksgiving Day in 2024 fell on November 28th. Thanksgiving Day is a national holiday celebrated…
Oct 25, 2024, 16:13 | Blog
Amer Zeidan: Analyzing determinants of premature trial discontinuation in leukemia clinical trials
Amer Zeidan, Associate Professor of Medicine (Hematology) at Yale University, shared a post on X: "Our…
Oct 20, 2024, 02:48 | Insight
Oncology Brothers: Insights and Evolving Standards at ASH24
Oncology Brothers posted on X: “Going to ASH24? See you there to discuss the current…
Sep 21, 2024, 08:51 | Blog
Amer Zeidan: Matteo Della Porta about used of artificial intelligence in hematologic malignancies
Amer Zeidan shared a post on X: ''True pleasure to have Matteo Della Porta from…
Sep 18, 2024, 22:46 | Blog
Amer Zeidan: The 7th annual NEHEME New England Hematologic Diseases Symposium
Amer Zeidan shared on X: "Outstanding meeting with excellent speakers and very engaged discussion at the…
Sep 17, 2024, 16:48 | Blog
Vincent Rajkumar: A simplified algorithm of frontline therapy for myeloma
Vincent Rajkumar shared a post on X: "Thanks Dr. Amer Zeidan for inviting me to…
Jul 28, 2024, 07:48 | Blog
Amer Zeidan: An opportunity for classical hematology/hematologic oncology trainees to attend annual NEHEME meeting
Amer Zeidan, Associate Professor of Department of Internal Medicine and Hematology at Yale School of…
Jul 27, 2024, 12:01 | Blog
Ask the Expert with Amer Zeidan
Amer Zeidan, Associate Professor of Department of Internal Medicine and Hematology at Yale School of…
Jul 24, 2024, 06:20 | Blog
Naveen Pemmaraju: Co-chairing the inaugural International Workshop on MPN24 meeting
Naveen Pemmaraju shared on LinkedIn: "I recently had the opportunity to co-chair with Prof Claire…
Jul 15, 2024, 21:23 | Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
Jul 15, 2024, 07:03 | Blog
Amer Zeidan: Our 2nd International Consortium for MDS
Amer Zeidan shared a post on X:   . "Our 2nd International Consortium for MDS (icMDS)…
Jul 7, 2024, 16:11 | Insight
Amer Zeidan: Excellent paper by Abdulrahman Alhajahjeh under mentorship of Maximilian Stahl
Amer Zeidan shared a post on X: "Another excellent paper by University of Jordan super…
Jul 7, 2024, 15:49 | Blog
Kelly Norsworthy: Submit your Pragmatic Trials ideas to FDA Oncology
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared…
Jul 6, 2024, 12:30 | Opinion
Discussions around ABIM MOC
The discussions among ABIM's Maintaining Certification (MOC) program continue on X/Twitter. This time a conversation…
Jul 3, 2024, 18:25 | Blog
Amer Zeidan: Big data and quality of life measures to improve outcomes of MDS patients in iwMDS24 with talks from Spain
Amer Zeidan shared on X: "Mikkael A. Sekeres and Hetty Carraway moderating a great session about…
Jun 26, 2024, 05:07 | Blog
ECOG-ACRIN Cancer Research Group study EA9171 is enrolling patients for a clinical trial on Chronic Myeloid leukemia
ECOG-ACRIN Cancer Research Group shared a post on X: “Dr. Amer Zeidan of Smilow Cancer…
Jun 21, 2024, 08:22 | Blog
Amer Zeidan: Two additional studies from EHA2024 confirm validity of IWG2023
Amer Zeidan shared on X:               . "Two additional studies from…
Jun 19, 2024, 23:22 | Blog
Amer Zeidan: Looking forward to finding cures for all AML and MDS patients
Amer Zeidan shared on X: "Looking forward to finding cures for all Acute Myeloid Leukemia…
Jun 19, 2024, 08:13 | Blog
Mikkael A. Sekeres: Look at this collection of myeloid malignancy gurus
Mikkael A. Sekeres, Chief of the Division of Hematology at Sylvester Comprehensive Cancer Center, shared a…
Jun 18, 2024, 17:31 | Insight
Amer Zeidan: Nothing is better than training international students on research
Amer Zeidan shared a post on X: “Nothing better training international students on research. True pleasure…
Jun 18, 2024, 14:51 | Insight
Amer Zeidan: Our newest paper on 61 TP53-mutated AML
Amer Zeidan shared on X: "Our newest paper with a detailed Integrated analysis of genetic,…
Jun 18, 2024, 03:11 | Blog
Amer Zeidan: Dr. Shahram Kordasti detailing the 'immunologic mess' in bone marrow failure conditions
Amer Zeidan shared a post on X: “Dr. Shahram Kordasti detailing the 'immunologic mess' in bone…
Jun 18, 2024, 02:37 | Blog
Amer Zeidan: A wonderful talk by Dr. Emma M. Groarke on targeting immune dysregulation in Myelodysplastic syndromes
Amer Zeidan shared a post on X: “A wonderful talk by Dr. Emma M. Groarke on…
Jun 17, 2024, 04:18 | Blog
Amer Zeidan: Amazing work by our fellows, 6 posters at EHA2024
Amer Zeidan shared on X/Twitter: "Amazing work by our fellows at Yale Hematology Oncology Fellows presenting…
Jun 15, 2024, 14:14 | Blog
Aditi Shastri: Important updates from Amer Zeidan in myelodysplastic syndrome at EHA2024
Aditi Shastri, Associate Professor of Medicine at Einstein SCI, shared on X: “Come to the…
Jun 15, 2024, 09:46 | Blog
Amer Zeidan: Amazing work by our Yale Hematology Oncology Fellows at EHA2024
Amer Zeidan shared a post on X: “Amazing work by our Yale Hematology Oncology Fellows presenting…
Jun 7, 2024, 13:38 | Blog
Anand Patel: Imetelstat approved for lower-risk MDS with anemia
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago,…
May 18, 2024, 12:07 | Insight
Amer Zeidan: Another great project led by super star Maximilian Stahl
Amer Zeidan shared a post on X: “Another great project led by super star Maximilian Stahl…
May 16, 2024, 09:22 | Blog
Amer Zeidan: True pleasure to be in the company of the MDSsm greats
Amer Zeidan shared a post on X: "True pleasure to be in the company of the…
May 13, 2024, 13:48 | Blog
Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia…
May 7, 2024, 10:51 | Blog
Maximilian Stahl: I’ll be at the Oncology Symposia in Conjunction With the 2024 ASCO Annual Meeting
Maximilian Stahl, Attending Physician in the Department of Medical Oncology at Dana-Farber Cancer Institute, shared…
May 3, 2024, 04:08 | Blog
Amer Zeidan: Few things NOT to do when asking for a research position
Amer Zeidan shared on X/Twitter: "Few things NOT to do when asking for a research rotation/position:…
Apr 27, 2024, 14:29 | Opinion
Amer Zeidan: I find MRD literature increasingly confusing as it pertains to decision making
Amer Zeidan shared a post on X: "I have to say I find MRD literature…
Mar 11, 2024, 03:24 | Career
Amer Zeidan was appointed as the inaugural Chief of the Division of Hematologic Malignancies at Yale Cancer Center
Yale Cancer Center shared on LinkedIn: "We are pleased to announce that Amer Zeidan was…
Mar 9, 2024, 12:53 | Blog
Amer Zeidan: No leukemia cell would stand a chance against this group
Amer Zeidan recently posted on X/Twitter: "No leukemia cell would stand a chance against this group."…
Mar 3, 2024, 06:19 | Blog
Amer Zeidan: When oncologists finally discovered they can make much more with less stress and more time for their families
Amer Zeidan shared on X/Twitter: ''These locum opportunities have become so lucrative for oncologists, and…
Feb 26, 2024, 19:30 | Blog
Amer Zeidan: What a talk by Marina Konopleva at Yale Cancer Center grand rounds
Amer Zeidan shared on X/Twitter: “What a talk by Marina Konopleva (who is one of…
Feb 23, 2024, 10:51 | Blog
Amer Zeidan: Just an unbelievable cascade of news for magrolimab
Amer Zeidan shared on X: "Just an unbelievable cascade of news for magrolimab … Gilead…
Feb 21, 2024, 17:14 | Blog
Susan Quaggin: Thrilled to host Dr. Amer Zeidan speaking on immune checkpoint inhibition and novel therapies for MDS
Amer Zeidan, Associate Professor of Hematology at Yale University, shared a post by Susan Quaggin's, Chair…
Jan 11, 2024, 18:11 | Blog
Amer Zeidan: Dr Mohamad Mohty continues to lead high value educational initiatives globally and in Middle East
Amer Zeidan, Associate Professor of Hematology at Yale University, shared a post on LinkedIn: "Dr Mohamad…
Dec 30, 2023, 03:53 | Opinion
Amer Zeidan: Being a fierce advocate for the patients
Amer Zeidan shared on X: "There are many good qualities that an academic physician can…
Dec 29, 2023, 15:53 | Opinion
Amer Zeidan: Why CROs shouldn’t be doing clinical research
Amer Zeidan shared on X: "If you have any doubt why CROs shouldn’t be doing…
Dec 20, 2023, 23:50 | Blog
Amer Zeidan: Meeting 1st mentor Peter Kouides every The American Society of Hematology (ASH) is a tradition I cherish
Amer Zeidan shared on X/Twitter: “Meeting 1st mentor Peter Kouides every The American Society of Hematology…
Dec 19, 2023, 18:10 | Positive
Amer Zeidan: And the call we had tonight made my week...
Amer Zeidan shared on X/Twitter: "One of my patients established a tradition where he and…
Dec 17, 2023, 16:13 | Positive
Mohammad Alhomoud: What would you do when you ran into 2 legendary mentors?
Quoting Mohammad Alhomoud, bone marrow transplant fellow at the Memorial Sloan Kettering Cancer Center, on…
Dec 15, 2023, 06:18 | Blog
Amer Zeidan: A proud moment as a mentor
Amer Zeidan shared a post on his X/Twitter page: "A proud moment as a mentor…
Dec 1, 2023, 18:42 | Insight
Amer Zeidan: Nice paper from MD Anderson Cancer Centre group on CPX-351 for HR MDS
Amer Zeidan shared on X/Twitter: "Nice paper from MD Anderson Cancer Centre group on CPX-351…
Nov 27, 2023, 16:36 | Insight
With Amer Zeidan, we discuss risk stratification, work-up and management of MDS - Oncology Brothers
Quoting Oncology Brothers on X/Twitter: ''With Amer Zeidan, we discuss risk stratification, work-up and management…
Nov 15, 2023, 17:01 | Blog
Amer Zeidan: How much better the world would be if some politicians had only 1% of decency of health care workers
Amer Zeidan posted on X/twitter: "Seeing health care workers (HCWs) working under unimaginable conditions with no…
Oct 30, 2023, 19:21 | Blog
Amer Zeidan: A watershed moment for Myelodysplastic syndromes
Amer Zeidan, shared a post on LinkedIn: "A watershed moment for Myelodysplastic syndromes with the first approval…
Oct 12, 2023, 02:22 | Blog
Amer Zeidan: Outstanding panel discussions on all aspects of MDSsm in IACH COMyDAL meeting.
Amer Zeidan, shared on X/Twitter: "Outstanding panel discussions on all aspects of MDSsm in IACH…
Oct 6, 2023, 17:11 | Insight
Amer Zeidan: How well does Allogeneic Hematopoietic Cell Transplantation (AlloHCT) work for Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCNsm?
Amer Zeidan, recently tweeted: "How well does Allogeneic Hematopoietic Cell Transplantation (AlloHCT) work for Blastic…
Sep 20, 2023, 18:22 | Societies
Amer Zeidan: So excited to see this meeting materialize after months of work to advance care of patients and research of hematologic malignancies in Middle East SOHOMENA 1st annual meeting.
Sep 18, 2023, 17:17 | Blog
Aditi Shastri: It was our absolute pleasure to host Amer Zeidan as our BCI honored guest this week!
Aditi Shastri, Associate Professor of Medicine at Einstein SCI, shared on X/Twitter: “It was our…
Sep 3, 2023, 17:34 | Positive
Amer Zeidan: Many thanks for the Pakistani hematology group for sending this kind gesture!
Quoting Amer Zeidan, on Twitter: "Many thanks for the Pakistani hematology group for sending this…
Aug 17, 2023, 16:33 | Blog
Amer Zeidan: It has been 16 years and 300 papers since my first paper was published in July 2007.
Amer Zeidan wrote in a recent tweet: ''It has been 16 years and 300 papers…
Aug 14, 2023, 16:41 | Blog
Amer Zeidan: Nothing like an excellent book during a long flight!
In a post on Twitter Amer Zeidan, Associate Professor of Internal Medicine at Yale University,…
Aug 11, 2023, 18:48 | Insight
Amer Zeidan: On behalf of an international panel, we issued a call-for-action to harmonize/unify WHO22 and ICC22 classifications for AML
On behalf of an international panel, we issued a call-for-action to harmonize/unify WHO22 & ICC22…
Aug 10, 2023, 18:21 | Stories
Deeply enjoyed recording a new MDS Sessions with pioneering Giants & taking a journey through history of MDS - Amer Zeidan
Deeply enjoyed recording a new MDS Sessions with pioneering Giants & taking a journey through…
Aug 6, 2023, 11:41 | Opinion
Good clinical practice does not mean endless and mindless tasks that no one knows why they exist aside from generating work and money for CROs - Amer Zeidan
If I am in charge of regulating trials i would cut down 50% of needless…
Jul 22, 2023, 02:20 | Opinion
If I happened to get 10 new AML patients in one night - Amer Zeidan
Quoting Amer Zeidan on Twitter, "If I happened to get 10 new AML patients in…
Jul 20, 2023, 16:11 | Blog
SOHO meeting of hematologic malignancies is coming to MENA region - Amer Zeidan
Exxcited that after almost a year of planning, SOHO meeting of hematologic malignancies is coming…
Jul 7, 2023, 06:28 | Stories
I am reminded of this famous quote - Amer Zeidan
I am reminded of this famous quote as we continue to actively push towards a…
Jun 18, 2023, 04:26 | Insight
A funny story from EHA2023 - Amer Zeidan
A funny story from EHA2023: After I gave a presentation on new therapies for MDS,…
Jun 14, 2023, 17:42 | Drugs
A great moment of progress - Amer Zeidan
A great moment of progress (& a personal pride for involvement) in lower risk MDS with…
All: 76 Posts: 1 - 100
Special Coverage